Cochrane plans to allay fears over industry influence.
Ray
R
Moynihan
D016265:Conflict of Interest; D004345:Drug Industry / Q000191:economics* / Q000941:ethics; D009935:Organizational Affiliation; D016134:Organizational Policy; D012109:Research Support as Topic / Q000941:ethics